Free Trial

IGC Pharma (IGC) Institutional Ownership

IGC Pharma logo
$0.32 +0.00 (+0.28%)
Closing price 05/7/2026 04:10 PM Eastern
Extended Trading
$0.32 +0.00 (+1.22%)
As of 05:19 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for IGC Pharma (NYSEAMERICAN:IGC)

Current
Institutional Ownership
Percentage
3.87%
Number of
Institutional Buyers
(last 12 months)
3
Total
Institutional Inflows
(last 12 months)
$175.93K
Number of
Institutional Sellers
(last 12 months)
1
Total
Institutional Outflows
(last 12 months)
$83.51K
Get IGC Insider Trade Alerts

Want to know when executives and insiders are buying or selling IGC Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

IGC Institutional Buying and Selling by Quarter

IGC Pharma Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/13/2026State Street Corp200,799$57K0.0%+25.3%0.211%
2/12/2026Renaissance Technologies LLC919,641$259K0.0%-24.6%0.968%
11/17/2025Citadel Advisors LLC627,840$262K0.0%+131.7%0.683%
11/14/2025Virtu Financial LLC89,546$37K0.0%+91.0%0.097%
2/17/2025Squarepoint Ops LLC125,966$42K0.0%N/A0.163%
2/14/2025Northern Trust Corp113,407$38K0.0%+59.7%0.146%
2/12/2025Geode Capital Management LLC669,685$225K0.0%+19.0%0.865%
11/20/2024Virtu Financial LLC123,060$53K0.0%+164.7%0.159%
11/16/2024Geode Capital Management LLC562,969$240K0.0%+31.0%0.744%
10/29/2024Fullcircle Wealth LLC103,443$42K0.0%N/A0.137%


IGC Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of IGC shares?

During the previous two years, the following institutional investors and hedge funds held shares of IGC Pharma shares: Citadel Advisors LLC ($262K), Renaissance Technologies LLC ($259K), Geode Capital Management LLC ($225K), State Street Corp ($57K), Squarepoint Ops LLC ($42K), Fullcircle Wealth LLC ($42K), and Northern Trust Corp ($38K).Learn more on IGC Pharma's institutional investors.

What percentage of IGC Pharma's stock is owned by institutional investors?

3.87% of IGC Pharma's stock is owned by institutional investors. Learn more on IGC's institutional investor holdings.

Which institutional investors have been buying IGC Pharma's stock?

The following institutional investors have purchased IGC Pharma's stock in the last 24 months: Citadel Advisors LLC ($356.87K), Geode Capital Management LLC ($239.86K), Squarepoint Ops LLC ($125.97K), Virtu Financial LLC ($119.22K), Fullcircle Wealth LLC ($103.44K), Northern Trust Corp ($42.38K), and State Street Corp ($40.59K).

How much institutional buying is happening at IGC Pharma?

Institutional investors have bought a total of 440,120 shares in the last 24 months. This purchase volume represents approximately $175.93K in transactions.

Which of IGC Pharma's major shareholders have been selling company stock?

The following institutional investors have sold IGC Pharma stock in the last 24 months: Renaissance Technologies LLC ($299.32K).

How much institutional selling is happening at IGC Pharma?

Institutional investors have sold a total of 299,324 shares in the last 24 months. This volume of shares sold represents approximately $83.51K in transactions.



This page (NYSEAMERICAN:IGC) was last updated on 5/8/2026 by MarketBeat.com Staff.
From Our Partners